MDClone (a leading analytics and synthetic data company) has partnered with the University of Chicago and UChicago Medicine to establish an ADAMS Center, a unified data-driven epicenter for innovation, research, and quality improvement projects for the health system. ADAMS represents the innovation process of Ask, Discover, Act, Measure, and then Share – focused on generating quicker insights at scale by fostering synergy among teams.
When the ADAMS Center is fully set up at Chicago Medicine by fall 2024, collaborators across the UChicago Medicine health system will have the benefit of the learnings and knowledge of other ADAMS Centers in MDClone’s Global Network to ultimately:
1.) Transform the health system into a continuous learning environment aligned with leadership goals and objectives
2.) Empower research and clinical teams to be champions of change through faster and easier access to information
3.) Safely leverage synthetic data to establish collaboration with external partners
The ADAMS Center will enable the UChicago Medicine health system to accelerate research, evaluate and improve care delivery, and seek new innovative partnerships by making data available faster with self-service tools and safer by providing synthetic data when appropriate to clinicians, trainees, and administrators. The data will be collected from various clinical, financial, and health information systems. MDClone can convert the data into reliable synthetic data to protect sensitive health information.
KEY QUOTES:
“This partnership will reimagine the way data is used by UChicago Medicine. It will empower clinical teams to lead meaningful change to care delivery and to streamline research and quality improvement activity.”
- Tom Spiegel, MD, Chief Quality Officer for the UChicago Medicine health system
“The hospital of the future requires data-driven decision making, but many hospitals are challenged by operational bottlenecks and resource shortages that present barriers to achieving this important goal. We are proud to collaborate with such a prestigious institution to build the next US ADAMS Center that will yield new insights and discoveries.”
- Ziv Ofek, Founder and CEO of MDClone
